Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

OUCRU laboratories provide support to the unit’s extensive clinical research programme, from level 2 laboratory to SAPO 4 laboratory for high-risk pathogens responsible for zoonotic infections. Early diagnosis and detection of antimicrobial resistance helps prescribe the right medicine in time, contributing to better patient management.

My name is Motiur Rahman, I work as Head of the Laboratory at Oxford University Clinical Research Unit in Ho Chi Minh City. My responsibility is to run a laboratory operation programme across OUCRU units in Vietnam, Indonesia and Nepal.

We have been conducting research on tuberculosis, dengue, malaria, brain infection, hepatitis for the last decades. We have been using advance genomics for early diagnosis and detection of antimicrobial resistance in mycobacterium that has been very successful. We have been monitoring antimicrobial resistance in malaria parasite for the last 20+ years. We also maintain an insectarium where we grow mosquitoes, and then we use these mosquitoes to infect dengue patients to see how long patients can remain infected with the mosquitoes.

We oversea three different types of laboratories. We have the general biosafety level 2 laboratory which deals with most of the pathogens we generally work with, then we have a biosafety level 3 laboratory which is mainly for dangerous pathogens, and then we also have a Specified Animal Pathogen Order 4 laboratory which is for high-risk pathogens for zoonotic infections. We have several programmes and our research projects are conducted through many different provincial hospitals. In every hospital we work with, we train the staff, we try to transfer technology, we bring the staff from there to come and visit our place, and then we also recruit MSc and PhD students to work in our laboratory. Capacity building is part of our laboratory programme that continues all the time.

When we do research on tuberculosis, we look for ways to diagnose the disease quickly and more accurately: we take research projects that particularly deal with early diagnosis and detect antimicrobial resistance simultaneously so that the patient can be prescribed with the right medicine in time. We have been conducting research on personalised medicine for tuberculosis in which we identified the patient’s genotype and then treat them based on that particular genotype which gives a more accurate treatment.

Our research on tuberculosis has changed or helped millions in the world to get the right diagnosis and right treatment in time. Our antimicrobial resistance monitoring programme taking the one health approach has helped Vietnam in reducing antibiotic use in livestock, poultry, fisheries, and has contributed significantly in reducing the antimicrobial resistance problem in Vietnam.

Going from research to practice and then back to research is one of our key objectives when we conduct research. In our clinical trials, treatment option, treatment duration and treatment regime are being defined and directly translated into patient management locally. Then those results are later translated into policy and contribute to patient management. Whatever we do here in Vietnam, this is very much translational research and our intent is to change local policy.

Motiur Rahman

Motiur Rahman works as Head of Laboratories for OUCRU in Ho Chi Minh City and oversees the OUCRU laboratory programme in Vietnam, Indonesia, Nepal, and China. Activities includes improving capacity, enhancing quality and ensuring regulatory compliance and safety of the OUCRU and other collaborating institute laboratories.

More podcasts related to Global Health

Mike English: Health services that deliver for newborns

Basic hospital care may be key to saving newborn lives. Professor Mike English outlines a multidisciplinary project engaging policy-makers and practitioners in Kenya. This project demonstrated poor coverage of Nairobi’s 4.25 million population if a sick newborn baby needs quality hospital care. Using novel research approaches the team also identified how severe shortages of nurses contribute to poor quality of care for patients and negatively affect nurses themselves.

Tran Hien: Infectious diseases in the tropics

Although incidence of malaria has decreased in Vietnam, the burden of infectious diseases remains high and weighs heavily on the health care system. Clinical research aims to allow investments to go further: findings in the laboratory, tested in clinical trials and then applied to the community, help improve diagnosis and management.

Ronald Geskus: Sophisticated biostatistics for complex clinical research

The role of biostatisticians in clinical research is to contribute to trial design, by calculating sample size for example, and to help draw correct conclusions from the data, discriminating important information from noise. They are instrumental in the translation of a practical problem into a statistical model, and the translation of the result into practice.

Rogier Van Doorn: Research at OUCRU Hanoi

Antibiotics are widely used in Vietnam, leading to widespread antimicrobial resistance. Monitoring antibiotic use helps inform the government to change treatment guidelines and implement antibiotic stewardship programmes. This may also prevent the transmission of resistant bacteria outside the country.

Heiman Wertheim: Clinical research in low and middle-income countries

Drug resistant infections are a global crisis and we cannot focus on our own country only. Clinical trials in low and middle income countries where the burden is highest, as well as work with local communities and engagement with policy makers help influence public health policies.

Guy Thwaites: Tuberculosis meningitis

Tuberculosis meningitis affects a fractions of TB patients but causes high levels of mortality and morbidity. A recent trial at OUCRU showed that aspirin can greatly improve outcomes. Such trial is typical of the work done in our Vietnam units, where all the research is focussed on improving the outcome for patients directly.

Raph Hamers: Developing collaborative clinical trials in Indonesia

Indonesia is a very populous country with a huge burden of infectious diseases such as TB, malaria, HIV and CNS infections. Running clinical trials requires high levels of expertise, currently developed and strengthened by institutions such as IOCRL (Universities of Indonesia and Oxford Clinical Research laboratory). Better collaborations will also help great ideas make a bigger impact.

Jeremy Day: Central nervous system and HIV infections in Vietnam

Brain infections such as meningitis and encephalitis are highly debilitating diseases, and an accurate diagnostic is essential to give patients the best treatment available. For cryptococcal meningitis, clinical trials focus on prevention, for an early diagnosis, and novel ways to use existing treatments or repurpose old drugs.

Abhilasha Karkey: Connecting research with communities in Nepal

Antimicrobial resistance is a huge burden in Nepal, particularly in hospitals where many nosocomial infections are caused by resistant pathogens. With limited resources, little infection controls and proper guidelines in place, finding out the main risk factors helps reduce infection rates within a hospital and better target vaccination campaigns.

Juan Carrique-Mas: Antimicrobial resistance in poultry production

Many households in Vietnam raise animals for food production, particularly chickens, using large amounts of antimicrobials with no veterinary support, and those antimicrobials find their way into the food chain. The ViParc project conducts intervention trials similar to human clinical trials, to help farmers reduce the level of antimicrobials used when raising chickens.

Translational Medicine

From Bench to Bedside

Ultimately, medical research must translate into improved treatments for patients. At the Nuffield Department of Medicine, our researchers collaborate to develop better health care, improved quality of life, and enhanced preventative measures for all patients. Our findings in the laboratory are translated into changes in clinical practice, from bench to bedside.